Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying Neuroone's stock, anticipating its value to rise significantly.
Financial Health
Neuroone Medical Technologies is generating modest revenue and cash flow, with a good profit margin.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring NMTC
Brain-Computer Interface
This collection features pioneering companies creating revolutionary pathways between the human brain and machines. These carefully selected stocks represent the cutting edge of neural technology, with potential to transform healthcare and computing through innovative brain signal interpretation.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Neuromodulation focus
The company targets devices for neurological conditions, an area with clinical demand — though clinical and regulatory outcomes can be uncertain.
Catalysts to watch
Regulatory approvals, trial readouts and commercial partnerships could move the story; these are binary events that carry both upside and downside.
Capital and runway
As a small‑cap firm, funding needs and potential dilution are important to monitor; limited cash reserves can affect development timelines.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
